...
首页> 外文期刊>Cell stem cell >Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
【24h】

Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response

机译:在瞬时p53介导的DNA损伤反应后,精确基因编辑保留造血干细胞功能

获取原文
获取原文并翻译 | 示例

摘要

Precise gene editing in hematopoietic stem and progenitor cells (HSPCs) holds promise for treating genetic diseases. However, responses triggered by programmable nucleases in HSPCs are poorly characterized and may negatively impact HSPC engraftment and long-term repopulation capacity. Here, we induced either one or several DNA double-stranded breaks (DSBs) with optimized zinc-finger and CRISPR/Cas9 nucleases and monitored DNA damage response (DDR) foci induction, cell-cycle progression, and transcriptional responses in HSPC sub-populations, with up to single-cell resolution. p53-mediated DDR pathway activation was the predominant response to even single-nuclease-induced DSBs across all HSPC subtypes analyzed. Excess DSB load and/or adeno-associated virus (AAV)-mediated delivery of DNA repair templates induced cumulative p53 pathway activation, constraining proliferation, yield, and engraftment of edited HSPCs. However, functional impairment was reversible when DDR burden was low and could be overcome by transient p53 inhibition. These findings provide molecular and functional evidence for feasible and seamless gene editing in HSPCs.
机译:造血干细胞和祖细胞(HSPCS)中的精确基因编辑持有治疗遗传疾病的承担。然而,在HSPCS中由可编程核酸酶引发的反应表征差,并且可能会对HSPC植入和长期重新流量产生负面影响。在这里,我们诱导了一种或几种或几种或几种DNA双链破裂(DSB),优化的锌 - 手指和CRISPR / CAS9核酸酶,并监测了HSPC子群体中的DNA损伤响应(DDR)焦点诱导,细胞周期进展和转录反应,直到单细胞分辨率。 P53介导的DDR途径活化是对分析所有HSPC亚型的甚至单核素酶诱导的DSB致力于致力于均匀的响应。过量的DSB负荷和/或腺相关病毒(AAV)介导的DNA修复模板递送诱导累积P53途径激活,限制编辑HSPC的增殖,产率和植入。然而,当DDR负担较低时功能损伤是可逆的,并且可以通过瞬态P53抑制来克服。这些发现提供了Hspcs中可行和无缝基因的分子和功能证据。

著录项

  • 来源
    《Cell stem cell 》 |2019年第4期| 共23页
  • 作者单位

    IRCCS San Raffaele Sci Inst San Raffaele Telethon Inst Gene Therapy SR Tiget I-20132 Milan Italy;

    IRCCS San Raffaele Sci Inst San Raffaele Telethon Inst Gene Therapy SR Tiget I-20132 Milan Italy;

    IRCCS San Raffaele Sci Inst San Raffaele Telethon Inst Gene Therapy SR Tiget I-20132 Milan Italy;

    IRCCS San Raffaele Sci Inst San Raffaele Telethon Inst Gene Therapy SR Tiget I-20132 Milan Italy;

    IRCCS San Raffaele Sci Inst San Raffaele Telethon Inst Gene Therapy SR Tiget I-20132 Milan Italy;

    IRCCS San Raffaele Sci Inst San Raffaele Telethon Inst Gene Therapy SR Tiget I-20132 Milan Italy;

    Milano Bicocca Univ I-20126 Milan Italy;

    IRCCS San Raffaele Sci Inst San Raffaele Telethon Inst Gene Therapy SR Tiget I-20132 Milan Italy;

    IRCCS San Raffaele Sci Inst San Raffaele Telethon Inst Gene Therapy SR Tiget I-20132 Milan Italy;

    Fdn IRCCS Ist Nazl Tumori Milano Dept Expt Oncol Tumor Genom Unit I-20133 Milan Italy;

    Inst Cochin Inserm U1016 F-75014 Paris France;

    Inst Cochin Inserm U1016 F-75014 Paris France;

    Univ Vita Salute San Raffaele CUSSB Univ Ctr Stat Biomed Sci I-20132 Milan Italy;

    Inst Cochin Inserm U1016 F-75014 Paris France;

    IRCCS San Raffaele Sci Inst San Raffaele Telethon Inst Gene Therapy SR Tiget I-20132 Milan Italy;

    CNR Inst Biomed Technol I-20090 Segrate Italy;

    IRCCS San Raffaele Sci Inst San Raffaele Telethon Inst Gene Therapy SR Tiget I-20132 Milan Italy;

    IRCCS San Raffaele Sci Inst San Raffaele Telethon Inst Gene Therapy SR Tiget I-20132 Milan Italy;

    IRCCS San Raffaele Sci Inst San Raffaele Telethon Inst Gene Therapy SR Tiget I-20132 Milan Italy;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号